A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,715,663 shares of CNTA stock, worth $46.6 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,715,663
Previous 1,762,004 54.12%
Holding current value
$46.6 Million
Previous $15.9 Million 172.93%
% of portfolio
0.12%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.58 - $16.99 $8.18 Million - $16.2 Million
953,659 Added 54.12%
2,715,663 $43.4 Million
Q2 2024

Aug 14, 2024

SELL
$8.04 - $11.87 $3.99 Million - $5.88 Million
-495,714 Reduced 21.96%
1,762,004 $15.9 Million
Q1 2024

May 15, 2024

BUY
$6.73 - $12.2 $2.81 Million - $5.09 Million
417,236 Added 22.67%
2,257,718 $25.5 Million
Q3 2023

Nov 14, 2023

SELL
$6.01 - $8.24 $1.03 Million - $1.41 Million
-170,906 Reduced 8.5%
1,840,482 $11.9 Million
Q2 2023

Aug 14, 2023

BUY
$3.68 - $6.9 $868,134 - $1.63 Million
235,906 Added 13.29%
2,011,388 $12.5 Million
Q1 2023

May 15, 2023

BUY
$3.03 - $4.0 $5.14 Million - $6.78 Million
1,695,782 Added 2127.71%
1,775,482 $6.84 Million
Q4 2022

Feb 14, 2023

SELL
$3.05 - $4.19 $116,205 - $159,639
-38,100 Reduced 32.34%
79,700 $247,000
Q3 2022

Nov 14, 2022

SELL
$3.8 - $5.91 $60,040 - $93,378
-15,800 Reduced 11.83%
117,800 $474,000
Q2 2022

Aug 15, 2022

SELL
$3.18 - $9.85 $2.46 Million - $7.62 Million
-773,400 Reduced 85.27%
133,600 $651,000
Q1 2022

May 16, 2022

SELL
$7.45 - $11.59 $1.42 Million - $2.21 Million
-190,908 Reduced 17.39%
907,000 $8.14 Million
Q4 2021

Feb 14, 2022

BUY
$10.99 - $17.54 $8.74 Million - $14 Million
795,708 Added 263.31%
1,097,908 $12.4 Million
Q3 2021

Nov 15, 2021

BUY
$16.7 - $23.11 $3.38 Million - $4.67 Million
202,200 Added 202.2%
302,200 $5.05 Million
Q2 2021

Aug 16, 2021

BUY
$21.71 - $25.66 $2.17 Million - $2.57 Million
100,000 New
100,000 $2.22 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.62B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.